International Development Committee
Oral evidence: Humanitarian situation in Ukraine, HC 706
Tuesday 3 November 2026
Ordered by the House of Commons to be published on 3 November 2026.
Members present: Sarah Champion (Chair); Tracy Gilbert; Noah Law; Brian Mathew; David Mundell; Tulip Siddiq; David Taylor.
Joint Committee on Human Rights member present: Alex Sobel.
Questions 1 - 35
Witnesses
I: Dr Elena Moshynets, Leading Research Fellow, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, and Dr Luke Moore, Consultant in Infectious Diseases, Microbiology & Virology, Chelsea and Westminster Hospital.
II: Alina Belobra, Senior Advocacy and Policy Advisor, Humanitarian NGO Platform in Ukraine, Mila Leonova, Director, Alliance UA CSO, and Illya Kletskovskyy, Director General, Ukrainian Red Cross Society.
Examination of witnesses
Witnesses: Dr Luke Moore and Dr Elena Moshynets.
Chair: Thank you to our witnesses on panel 1 for joining us at the International Development Select Committee. We are looking specifically at the humanitarian situation in Ukraine. It is with great sadness that we are having this session, because the war is continuing. Thank you for making the time to be with us. Could I ask the witnesses to introduce themselves? Elena, could you introduce yourself and who you work for?
Dr Moshynets: Thank you very much for the invitation. I am Elena Moshynets. I am a leading research fellow at the Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine, where I lead the Biofilm Study Group. I am a microbiologist, and I specialise in antimicrobial resistance, bacterial biofilms and multi-drug resistant infections. I also co-ordinate the Horizon Europe SURE-AMR project, which is aimed at strengthening Ukraine’s AMR research capacity through international co-operation in a One Health approach. My current work is particularly focused on the challenges of treating high-resistance bacterial infections in Ukraine, including combat-related infections.
Chair: Thank you very much. Dr Luke, could you introduce yourself and your work?
Dr Moore: Good afternoon. My name is Luke Moore. I am a consultant medic here in London at the Chelsea and Westminster hospital. In my spare time, I am an academic at Imperial College London, where I focus on antibiotic resistance and how we , as a global community, can address that. I am a member of various learned societies, and editor at the Journal of Hospital Infection, where we focus on how, as a globe, we can combat antibiotic resistance.
Elena, could you give us an overview of the current healthcare situation in Ukraine? Then I will ask Dr Luke to go into the antimicrobials. So just the general health situation, please.
Dr Moshynets: Let me try to guide you through the problems we have now with medical system care in Ukraine. I should start with the fact that Ukraine’s healthcare system is in a stage of reformation. This reform was launched in 2022, and its aim is to bring healthcare financing and service delivery closer to western standards. However, it began in the same year as Russia’s full-scale invasion of Ukraine and continued despite the unprecedented challenges caused by the war. It is without adequate adaptation to the new realities or sufficient consideration of the rapidly deteriorating healthcare infrastructures, financing constraints and changing medical needs.
As a result, the healthcare system is expected to implement extensive structural and regulatory changes under wartime conditions without sufficient financial resources, institutional preparation or workflow development. In particular, Ukraine lacks a comprehensive system of national clinical guidelines for antimicrobial treatment, a sufficient number of trained specialists in antimicrobial resistance and infection prevention and control, and dedicated hospital funding to implement the new requirements.
I would say that infection prevention and control is particularly difficult to implement in those circumstances. Low salaries, staff shortages and extensive workloads have a severe influence and have resulted in the problems that we have now with infection prevention and control requirements. In some hospitals, one nurse is responsible for 40 to 60 beds, making consistent implementation of basic infection prevention measures extremely difficult.
I should also say that the further stage of healthcare reform has resulted in a consolidation of healthcare facilities, hospital mergers and the closure of additional institutions and hospitals that are unable to provide the expanded range of services required under the new system. Regional hospitals are particularly in trouble because they are smaller and cannot provide the full range of services. That is why they are considered for closure.
This approach gives rise to serious concerns in the context of healthcare-associated infections, and AMR specifically, because concentrating large numbers of patients in fewer hospitals increases the pressures on infrastructure, healthcare personnel and infection control systems, potentially facilitating the transmission of healthcare-associated infections. At a time when Ukraine faces a substantial burden of infection caused by multi-drug resistant bacteria, healthcare planning should prioritise improving hospital capacity, recruiting and appropriate patient-to-staff ratios, rather than further concentrating patient populations in a smaller number of hospitals.
Another problem we have now is access to publicly funded medical care. This access is deteriorating, particularly outside major urban cities. Hospitals face a shortage of antibiotics and other essential medicines, while regional and local authorities, whose budgets have been severely depleted by the war, are increasingly unable to compensate for those gaps in national healthcare financing. Consequently, regional healthcare provision is deteriorating faster than in major cities, creating growing inequalities in access to medical services and effective treatment.
This problem is specifically important in regions where war activities are happening. It also includes community-acquired infections, such as leptospirosis, Lyme disease, pyelonephritis and pneumonia. The further damage of energy infrastructures and other problems related to war just make the situation even worse because people cannot get access to specialised medical treatment.
Another problem I would like to mention is that treating infections caused by highly resistant bacteria is becoming increasingly difficult due to the limited availability of last-resort antibiotics. Some essential antimicrobial agents are either not registered or are unavailable on the Ukrainian pharmaceutical market, while others cannot be procured by hospitals because of insufficient funding. Consequently, even when microbiological diagnostics identify the appropriate treatment, clinicians may have no practical means to provide it. This creates a dangerous gap between identifying effective antibiotics and actual delivery of those antibiotics to the patient.
This is a very general overview. I just mentioned what is most important on my side, but Luke may be able to add some comments.
Chair: We will go into some of the details and issues that you raise.
Dr Moore: Thank you very much, Ms Gilbert. Right now, there are more bacteria than there have ever been humans on the face of planet Earth. We reproduce, what, every 20 years? We teach our young. Our young are better than us. Bacteria do the same but, rather than having a generation every 20 years, they have a generation every 20 minutes. That means they have the ability to learn and adapt to everything that we are doing as humans in our human civilisation, including developing new antibiotics, developing new surgery and giving people chemotherapy for their cancer.
People often think about antibiotic resistance as being an issue for just an infection. You have a urinary tract infection, “Whoops, I cannot now give you a tablet antibiotic. I need to now bring you into hospital to treat.” Sure, that is part of it, but actually if you need a metal hip and you need surgery, if you need chemotherapy or if you have diabetes and get a manky foot, I cannot now manage that as effectively as I could have 20 or 30 years ago.
Just coming back to that time issue, the amount of money and time it takes to develop a new antibiotic I think is replete in the media—20 years, $2 billion. Yet, as I alluded to, these bacteria are reproducing every 20 minutes, and there are so many of them on each of us.
If we, as human healthcare, are trying to enable longevity, and enable health rather than ill health, we need to address how we enable the rest of healthcare to be undertaken. We need to support that with antibiotics. That is the status quo in a reasonably resource-replete healthcare organisation, which is national and is not in the midst of conflict and catastrophe.
Add into that conflict and catastrophe; huge internal or external displacement of hundreds of thousands of citizens; dissolution of the infrastructure where we actually provide healthcare—the organisations, the buildings in which we do it; and removal of healthcare providers, through casualties or displacement to other countries, and suddenly you take a severe issue for the whole of healthcare and compound it.
What we are facing now in areas of conflict and catastrophe such as Ukraine is an inability to treat infections with any antibiotic. We have increased spread of those resistant bacteria from citizens who have an injury because of the conflict to citizens in beds next to them, who may have come in for a pacemaker or a hip replacement. That exponential increase in the problem of antibiotic resistance undermines all of healthcare provision in Ukraine.
What we have then seen in the United Kingdom, the Netherlands, Poland and Germany is movement of citizens from conflict areas such as Ukraine to our healthcare organisations, again with an exponential increase in the dissemination of those resistant bugs. We kind of understand borders; bacteria don’t.
Dr Moore: Elena and her team, and our disparate team here in the UK, have been collaborating for several years, most recently with financial support from UK Defence Innovation, which has given us an ability to form a formal network looking at conflict wound infections. That includes universities in the UK such as Birmingham, Imperial College and Strathclyde, and Great Ormond Street hospital, as well as Elena and the National Academy of Sciences of Ukraine. We have been building a network of excellence—as much as we can all be excellent together, but also, much more functionally than that—to look at the types of bugs, the types of drugs that are still effective, and how we can deploy diagnostics to improve in situ diagnosis of resistant infections as close to the frontline as we can. I hope, Elena, that that is of use on the shop floor, but it also provides us here in the UK with resilience, should we need it further down the line.
Dr Moore: It is the MOD.
David Mundell: So that is defence-related funding. Is there more that the MOD, the FCDO or the Health Department could do to support your work?
Dr Moore: Yes, I wish, Mr Mundell. Our collaboration initially started with some very small grants. We have a learned society called the Healthcare Infection Society. It gave us a small stand-up grant. At my own hospital, Chelsea and Westminster, we have a charitable fund. It gave us a small start-up grant. With that, we were able to roll forward to this UKDI grant. There are other pockets of UK money. I don’t know whether FCDO has any pockets of money to help us with Ukraine antibiotic resistance issues.
Dr Moore: Unequivocally, yes, they are supportive.
David Mundell: We are very interested in the “transfer” of what previously were perhaps ODA funds into defence-related matters.
Dr Moore: Yes.
David Mundell: This is not a matter I had considered might fall within that category.
Dr Moore: UKDI are very supportive. I do not have a bad word to say about UKDI.
Chair: That is good to hear. Thank you.
Dr Moshynets: This is a very complicated story, and it has a few problems associated with it. The major problem now in Ukraine is the growing gap between the increasingly complex regulatory framework established by the Ministry of Health and the actual capacity of hospitals to comply with those standards. The healthcare facilities are expected to meet extensive clinical administrative requirements, but often lack the financial and material resources to do that. In practice, responsibility for providing appropriate treatment is increasingly transferred from Government institutions to hospitals and individual clinicians, even when the necessary medicines are simply unavailable.
This is really creating an extremely difficult ethical and practical clinical dilemma for clinicians. They may have to prescribe antibiotics that are available in the hospitals, even when those are not the most appropriate options for the treatment of this disease, or ask patients to purchase the required medicines themselves. The latter is particularly problematic because patients are officially promised the provision of free medical care. That means that doctors may be blamed for corruption when asking the patient to buy essential medicine. So that is really a problem—a psychological problem, even.
The consequences for antimicrobial treatment are rather serious because antibiotics may be selected according to what the hospital can afford or has in stock, rather than what microbiological susceptibility suggests should be used. In some cases, clinicians may even hesitate to request bacterial culturing and to provide the specific diagnostics, simply because they expect that they will not be able to treat the infections they may identify. In fact, sometimes they will miss the diagnostics because they expect a high resistance rate, which they cannot treat according to—I won't say “recommendations”, but let’s say the antibiogram. This creates a dangerous cycle, where inadequate funding and limited access to appropriate antibiotics compromise treatment, undermine antimicrobial stewardship and may accelerate the emergence and spread of antimicrobial resistance further.
The other problem related to this issue, which I would also like to mention, is the lack of a comprehensive, nationally co-ordinated and adequately implemented system of clinical guidelines for the treatment of infectious diseases in Ukraine, particularly multi-drug resistant infections. I should also mention that simply adopting recommendations developed by leading Western medical infectious disease societies is not sufficient in Ukraine, because those guidelines should provide not just an essential scientific foundation, but also treatment strategies that reflect Ukraine’s local resistance patterns, bacterial epidemiology diagnostics capacity and, of course, the actual availability and affordability of those antibiotics. That is crucially important.
Ukraine urgently needs evidence-based national treatment guidelines that are adapted to the epidemiological situation and healthcare resources. This is essential. Guidelines alone will not solve the problem; the Government must also ensure nationwide access to the required antibiotics, according to those guidelines. Decisions about which essential antibiotics should be available and publicly funded must be made at the national level. It should not be hospitals or just clinicians that develop the standard. There should be national expertise to offer protocols to clinicians in Ukraine, with all the recommendations being science based and practice based, but still rational in the reality of Ukraine. We cannot have national standards of care without national responsibility for ensuring access to the medicines that are required to meet those standards.
Chair: Thank you. Let me pause you there, because I think Dr Luke wants to come in as well.
Dr Moore: When I think of the antibiotic availability across the globe, including in Ukraine, there are issues with licensing and regulation. As Elena said, many of the reserve-line antimicrobials that we would use here are just not available in many countries, including in Ukraine.
Then you have issues with counterfeit and substandard medications, including because of failure of the supply chain—cold chain—and that is a particular issue in areas of conflict. So you have access to the antibiotic, but the antibiotic compound itself is degraded.
Then, as Elena said, you have issues with reimbursement strategies. We are very lucky here in that, at the point of care, nobody pays for medicine. That is not true in many areas of the world, including in Ukraine.
Then you have issues with abnormalities in the economics of a drug cost versus a diagnostic cost, meaning that, if you come to me with an infection, sometimes it is cheaper for me to prescribe you best-guess antibiotic 1, then 2, then 3, then 4, getting it wrong each time, contributing to antibiotic resistance each time, because that approach is cheaper than doing one diagnostic test where I give you the right drug at the first guess. Sorry, Elena, sorry to butt in there.
Dr Moshynets: Thank you so much for this clarification, can I just—
Chair: I think Tulip has another question.
Dr Moshynets: In Ukraine, many reserve antibiotics are definitely not registered. That is true. The other truth is that we have problems with those antibiotics that are not so expensive and not so innovative, let’s say. They are still unavailable because, as we mentioned, the pharmaceutical market is very small and vendors simply do not bring them to the Ukrainian market.
I have an example that explains how bad everything is in Ukraine. A few weeks ago, we had a new paper published by the Public Health Centre describing wound infections. They stated that almost every second war-related wound infection is a gram-negative multi-drug resistant infection. That means that, to treat those wounds, doctors need to prescribe reserve antibiotics. According to that paper, almost half of the antibiotics purchased in the medical system should be from this reserve group. In fact—I just specifically calculated this—based on the Ukrainian electronic procurement platform, which every hospital is obliged to use, in 2024 the total amount of reserve antibiotics purchased by hospitals was only 1.37%. This is mostly because of the price. This is a huge discrepancy between the cumulative resistance to hospital-acquired infections in Ukrainian hospitals and the antibiotics that are purchased and prescribed to treat those infections. That is the best way to illustrate the discrepancy between the reality and the affordability from the hospital side.
Dr Moore: Just zooming out a little bit to global health, in a reasonably resource-replete society, we focus a lot on non-communicable diseases—cardiovascular health and diabetes. In areas of the world where there are fewer resources, the weight of healthcare is still in communicable diseases. We are talking a lot about infections and antibiotic resistance, and that might not resonate so much here, but actually in areas of the world with fewer resources, infectious diseases still trump non-communicable diseases, and that is why this is so important.
Dr Moshynets: Thank you for this question. I wish I knew the answer. It is true that I am not a fan of the previous system. There were a lot of problems with the previous system. I do not know the answer to the question of why the national medical system decided on this reform despite the war. I would postpone this. It looks like there was a strong recommendation not to stop the planned reform and to move it forward. This reform really changes everything, even the structure of the hospital, the availability of antibiotics, and the availability of the other medicines. Everything is absolutely different to what we had before.
The other question is why this reform was not planned for smaller regions and upscaled later if it was effective. I still do not know the answer. The real problem—observing the number of resistant strains, and really looking at the bigger problem with the medical system—is why this reform was not adjusted to the gaps we can observe now. That is the question. It looks like the reform was planned and there are no corrections being suggested to it.
What should I say? We understand now that there are a number of problems, and it looks like the Minister of Health is now trying to find a solution for a number of gaps. I recently went to a specific meeting dedicated to AMR in Ukraine, which was organised by the Robert Koch Institute and the Charité hospital in Berlin. It looks like a decision has been made to formulate a specific fund for reserve antibiotics, which could be donated by Ukraine’s partners and distributed through the hospitals. But that is the original system we used to have before the reforms. It looks like they have tried to compensate for the problems and come back to the initial state because, with the resources we have in Ukraine, this reform is absolutely impossible to implement.
It is not only about funds; it is also about specialists. The core idea of this reform is to introduce another system for infection control and prevention. That means every hospital must have specialists in infection control and AMR, and we simply do not have enough specialists in Ukraine. This reform starts without a financial background, and without the number of specialists that could be employed by the hospitals, so there are still many questions about this reform.
It is my personal opinion that the main problem is the availability of antibiotics and the cost of evidence-based treatment. That is the main problem now.
Dr Moshynets: True. With this reform, it looks like the idea of distributing the funds through the hospitals has been inspired by the American system. The treatment of patients is covered by insurance companies. Our insurance is the state. But, in fact, instead of covering the whole cost of the patient’s treatment, the state decided to allocate a specific budget for every nosology—for every, let’s say, disease—but the cost does not correspond with the real expense of the treatment. That is why all those reserve antibiotics really cannot be covered by the budget. They are in there, but the money is simply not enough. That is the main problem. Now we are just balancing between the very limited resources for every disease and the real cost of those diseases.
There is nothing about the salary for the staff because, as I already mentioned, the shortage of nurses, clinicians and doctors has made a strong impact on the IPC—infection prevention control—situation. The fewer nurses we have, the less safe our hospitals are. I would say that there is a direct correlation between the salaries, availability of nurses and the quality of medical care.
Dr Moshynets: The reform was intended to bring Ukraine’s healthcare system up to the best western European standards. But, as I already mentioned, Ukraine was not prepared well for the system. I really support the idea of improving the healthcare system to a western standard, because that is much better than the system we used to have. But like I said, all these preparations should be done, and the transformation from the old standards to the current western European standards could potentially take 15 to 20 years. So it is not only about money; it is about time, and we didn’t have the time. This reform started to be implemented quite fast, and the requirements we have now do not match the dedicated funding, resources, personnel or anything, to say nothing about the war. Even without the war, it could be very difficult, because this reform really should take at least 20 years. So this is a problem.
I would like to briefly remind you that, first of all, there are established infection control teams. We need enough personnel to complete those teams, which we do not have. Another problem, which I should also mention, is something I have experienced myself. Part of this reform is to make prescription requirements for antibiotics stronger, to reduce the inappropriate use of antibiotics. That would work in western countries, but in the current Ukraine it is not adequately accompanied by measures to ensure access to medical consultations. On the one side, antibiotics are strictly restricted; on the other side, no medical assistance is available.
This is something that I saw myself during winter. There were blackouts and heating disruptions in Kyiv, and all those difficulties, and many people—specifically elderly people—were not able to visit the doctor. I have personally become aware of deaths in Kyiv reportedly associated with pneumonia. That is simply because patients are unable to visit doctors and get antibiotics that could treat the pneumonia. We do not have epidemiological data about that, but it is something that I saw myself and it is really very sad. Two years ago, those people could go to a chemist’s shop and buy antibiotics to support themselves. Like I said, that is not appropriate for western countries. In countries in need, such as Ukraine, perhaps priority should be given.
What should I suggest to the WHO, if I may of course? First, this healthcare reform cannot simply transfer western European standards into countries with very different financial, institutional and security conditions. Secondly, new standards must be accompanied by realistic funding, workforce development and the resources needed for implementation. That is super-important.
Of course, thirdly, reforms should be flexible. That is again very important to understand. Those reforms should be introduced progressively and tested before nationwide implementation. That again was not done here. The impact of those reforms must be continuously monitored, with the possibility to adjust when problems are noticed.
My final conclusion might be that international organisations, such as the WHO, must listen to healthcare professionals working on the ground in Ukraine. I do not observe that a lot. It looks like we have been told what to do, instead of us discussing what to do. Again, that is my personal opinion; I might be wrong. It is just my feeling, so maybe someone would not agree with me.
Stepping back from specifically focusing on Ukraine and looking more globally, I think about 130 conflicts are happening around the world at the moment. I know that AMR infections and resistance are ever increasing. What would your advice be to the World Health Organisation when it comes to dealing with the consequences when you have mass casualties and AMR? But, also, how should countries around the world insulate themselves from the risks of AMR?
Dr Moore: Yes, insulate.
Chair: Sorry, a snappy question.
Dr Moore: I guess there are several different ways to think about that. Way back in 2015, which seems many moons ago now, the WHO launched its global action plan on antibiotic resistance. It said that all 200-ish member states should write their own national action plans. Fast-forward to now, and about 150 of the 200 have done that.
I have spent most of the last three years analysing the different 150-ish national action plans that are out there, trying to find what good looks like. I have learned several things from that. There is no good. There are different elements that work for different countries. Some countries, in their national action plans, appear to have lifted en masse things that have worked elsewhere, thinking that this would be a good idea, and have tried to plug those into their own. As Elena said, it does not work.
So the No. 1 piece of advice to WHO is, “Thank you for commissioning all 200-ish member states to write their own national action plans. Please now review that and have a think about how we can all learn from each other’s national action plans. That does not mean copy. That means learn from each other’s plans.” That is point No. 1.
Point No. 2 was that, in that analysis of how different people are trying to address antibiotic resistance, some have tried to run before they can walk. Again, that resonates with what Elena was saying. There is no golden answer to antibiotic resistance; the answer does not have to be, for any given country, an expensive, all-singing, all-dancing solution. There are some examples in different countries’ national action plans that are really low cost and have worked far better than some elements of our own national action plan to address specific areas of antibiotic resistance. What a shame that the WHO isn’t facilitating that learning between countries. That is point No. 2.
Point No. 3 is around resilience, technology and AI. Now, I am not clever enough to know anything about AI, but it seems to me that we have huge numbers of data streams in healthcare in general, and in civilisation in general, so we can use other things, that are perhaps better than human brains, to elicit answers from to feed forwards into antibiotic resistance. In certain areas of the world—such as us, such as much of North America—we have huge electronic healthcare records. Why are we not leveraging AI in that format to extract ways to improve non-communicable health? I know that certain elements of AI are doing that for diabetes and renal disease. That is lovely, but where is that for antibiotic resistance? If the WHO has flagged AMR as a global silent pandemic, where are we with leveraging technology to help with that?
In my research group, I have the most fabulous research fellow I have ever come across, who has travelled up mountains in Greenland that have never been climbed before, gone to Antarctica and shrunken technology to be able to diagnose pathogens and antibiotic resistance genes in areas of the world in a way that you would never think was possible. That is lovely, but where can we do that en masse? Where can we do that at scale? If there is a conflict in a cold area, or a catastrophe in a hot area or a remote area, how can we deploy diagnostics to improve infection management—and AMR, but infection management in general—in those remote areas?
That is a kind of a high-tech specific funding issue. As I said, there is no single answer, Ms Champion, but it ranges from policy all the way through to R&D. In the UK, we have expertise. We have leadership, with Sally Davies in the field of AMR, but we need to live up to that and work where we can to feed up to the WHO that we can help with this.
Dr Moore: Correct.
Chair: That is very concerning. Do Committee members have additional questions for our witnesses? No? Thank you very much. That has been hugely interesting and really quite scary. Thank you ever so much for sharing your knowledge and experience. You are most welcome if you want to sit in the gallery for the second panel.
Examination of witnesses
Witnesses: Alina Belobra, Mila Leonova and Illya Kletskovskyy.
Chair: We are now continuing our session on the humanitarian situation in Ukraine. Thank you very much, witnesses, for coming before us. Could I ask you introduce yourselves? Mila, could I start with you?
Mila Leonova: Thank you so much. It is a great pleasure and honour to be here. My name is Mila Leonova. I am the director of the Alliance of Ukrainian Civil Society Organisations.
Alina Belobra: Thank you for welcoming me here. My name is Alina Belobra. I am representing the Humanitarian NGO Platform as a senior advocacy and policy adviser.
Alina, in the first panel we looked very much at the health situation—and particularly at antibiotic resistance—in Ukraine. Could you describe to us the broader humanitarian situation in Ukraine right now?
Alina Belobra: In general, this year, in comparison to previous years, is discussed within the humanitarian sector as an exacerbated protection crisis. Last year, we were talking about it, but this year we are seeing increased numbers of civilians who have been targeted with different weaponry—with longer-range missiles and longer-range drones. Basically, the monthly number of children killed this summer—this July—is the four-year highest we have faced in Ukraine. Long-range missiles and drones caused almost 50% of civilian casualties in August this year.
We are talking about big cities, like Kyiv, Kherson, Zaporizhia, and some frontline areas as well—so not only frontline areas, but also the centre and the west of the country. Also, if you overlap it with attacks on energy, warehouses, gas infrastructure, telecommunications infrastructure, railways and logistics, you see that people are cut off from access to services, but also that supply chains are disrupted to the extent that humanitarians experience difficulties providing aid.
I want to give you an example, since we have just had the healthcare session. Before coming here, we at NGO Platform consulted our NGO members working on healthcare issues. From conversation with them, we understand that the severity of attacks on humanitarians and also on pharmaceutical warehouses is so high that medical supply chains are disrupted. Anecdotally from the NGOs, we know that it is becoming harder to store medicine and to provide medicine to affected populations in frontline areas, and especially to keep medicine that needs to be kept in cold storage.
Alina Belobra: The first change that you will observe is the change in the air raid alerts. We no longer call it resilience; we call it adaptation to the point where people do not react to the air raid alerts, because they last for 24 hours.
In frontline areas, the schools are moved into underground facilities. Maybe you heard that there was a severe attack in one of the small settlements, Komyshuvakha. The missile hit the underground school facility where aid was provided to people. There were a number of people collected there to be provided with aid. The underground facilities are becoming targets as well. If I was a mum with two children in a frontline area, presumably my kids would go either into an underground facility to study or stay with me at home, trying to study online. We hear different concerns about both approaches.
On top of that, the situation would also limit my economic income. My livelihood would depend on how much I earn while my husband, in the scenario you gave me, is on the frontline and is conscripted. The healthcare and the caregiving burden are the two main challenges, including the education for kids who cannot attend the schools, if the underground schools are not available or if the air raid alerts and attacks by drones are so consistent that you have no opportunity to bring your kids to a school.
Alina Belobra: Markets are functional in frontline areas, but access to markets can vary. Honestly, it depends on the city. Let me give you an example. If I am a resident of Kherson—you probably know Kherson—it becomes significantly difficult to access markets under the constant drone surveillance and so-called human safaris, as they are usually called.
Alina Belobra: Yes.
Chair: What is that relating to?
Alina Belobra: Let me explain this terminology, which was used in one of Human Rights Watch’s reports. This is the terminology that the citizens of Kherson started to use to refer to targeted drone attacks on the civilian population, when the drone picks a target—a civilian as a target or a vehicle as a target—and attacks without regard and without respect to IHL principles of distinction, to the point where access to hospital, access to markets, and market functionalities are threatened because of those attacks. We are at the point where, reportedly, according to Protection Cluster, we are talking about Kherson-ification of two other locations on the frontline in the east of Ukraine. We are about to observe similar drone targets without respect to IHL and without respect to the principle of distinction in several other places.
Chair: Thank you for painting that very grim picture. We are very fortunate to be joined now by Illya, who is the director general of the Ukrainian Red Cross Society. Thank you so much for making the time to join us. My colleague David Mundell has a question for you.
Illya Kletskovskyy: In my opinion—and not only in my opinion, but from the data—it is a complex humanitarian emergency in Ukraine. Obviously, we can concentrate on the protection needs as a priority because of the security situation and the attacks on civilian infrastructure.
Also, in terms of preparedness for the winter and the attacks on the energy and water infrastructure, we have a deprivation of utilities, which is at a very large scale and is compromising the lives and wellbeing of millions in Ukraine.
Also, right now we are expecting numbers of evacuees or people that will need evacuation from the frontline areas, and from those areas from zero to 20 or 30 km from the frontline—given the attacks on energy, utilities and water infrastructure—to increase.
If I had to distinguish one area, it would definitely be protection. However, we cannot understate the effects on healthcare, overstretching healthcare, overstretching social protection systems and education. So it is truly a complex emergency that the Ukrainian population is dealing with.
Alina Belobra: On HIV, I have no specific data to provide you with. But to reiterate the comment—I think Illya may have more insight on your particular question—yes, we do see more hits on storage. One of the mitigation measures that NGOs are trying to develop is underground storage facilities, but we are also trying to keep them very small and very dispersed throughout different locations and closer to the frontline to facilitate access to medicines for the population. Unfortunately, I cannot comment on the question more than that.
David Mundell: But it is an example of exactly what you were saying.
Alina Belobra: Yes, absolutely.
Illya Kletskovskyy: No, I cannot comment on HIV, to be honest, on the prevalence of rates or on the current situation.
Illya Kletskovskyy: In terms of humanitarian partners, quite a few warehouses have been damaged—I would say it is close to five. It depends also on the size. For the Ukraine Red Cross, two large warehouses have been damaged, but the warehousing at the frontline is under constant pressure.
The same goes for businesses. We can monitor that attacks are rather of an economic nature. The attacks would be targeting the economy and the logistics chain in Ukraine. This is a new dimension from mid this year. The missiles or ammunition are targeted not only on the frontline. The targets are moving to logistics and into the bigger cities and the urban cities. We need to closely consider that there are many more attacks on urban settlements, and also attacks to inflict damage on the economy.
To be honest, I do not have the equation in terms of the impact on the economy, but there are definitely impacts on people’s livelihoods. I am not only talking about attacks on gas stations and people’s limited ability, especially at the frontline, to get fuel. We can also see shortages and stores closing—grocery stores. There are shortages of particular supplies related to hygiene or food and of any other supplies being used by the general population.
Unfortunately, there is no data, that I have seen that the Government has produced or given, that can estimate right now the size of this impact. This is very much in continuation, and every day there are more attacks on the frontline and in the larger urban population settlements or on the big roads that affect or target warehouses, logistics or the economy in general.
Illya Kletskovskyy: I would conclude that this is economic warfare. The targeting is not particularly looking to deflect or deteriorate the Government’s ability to deliver on anything. I think that, a month ago, a big warehouse for children’s toys was attacked. It seems it was attacked deliberately, not because there is a very big need for toys to be delivered for Government reliability, but because when you attack a large or mid-size company, you can inflict damage; you can put more pressure on the population, and the population will be under greater stress. I would say this is truly economic warfare. Many warehouses have been attacked, in various businesses, from healthcare to, as I said, a toy warehouse.
Noah Law: Thank you.
Chair: I am going to bring in Alex Sobel, who chairs the Joint Committee on Human Rights and also the all-party parliamentary group on Ukraine. He has been your absolute champion in the Chamber, so it is a great pleasure that he is guesting with us today. Alex, over to you.
Mila Leonova: Thank you so much. I would love to say that we are speaking only about the humanitarian crisis, but we need to think not only about that but about development as well because our people do not live in fragments. It is very important to create this bridge between the humanitarian and the development parts, and that is why this UK policy and implementation of programmes is very important, because you support us with both humanitarian and development issues.
For example, we can have a great programme on social services or we can have support for a humanitarian thing. We understand that we need to combine these things. Illya and Alina already mentioned that we need to have support in the frontline areas, but the centre of Ukraine or the west of Ukraine, are not so popular. That is important to highlight, because if you would love to keep people there, we need to provide houses and work. That is why it is necessary to create such programmes.
Now we are thinking about cross-sectoral partnership and how we can build relationships between the private sector, civil society and Government, because this triangle is the solution. This year, we would love to present such a model for FCDO work, because Ukraine is not only—how should I say it?—a beggar; we are a provider of solutions. That is important not only for how we use this funding you support us with, but also for creating these programmes that you can use not only for Ukraine but for other crises.
Mila Leonova: For us this is a question now because the World Bank works with Government and with the private sector. We need to think about how to include civil society in this triangle. We have programmes like work programmes, and they use the Government for this. It is very important to introduce civil society as a good partner for this, because we already have livelihood projects, where we provide grants for people. So it is important to have civil society on board. This is still an issue.
I think that we need to work very closely with Government. The World Bank works, of course, with Government as partners in one window, and it is very hard to create a lot of different stream lines. I think that is important. For example, pooled funds—which we create in Ukraine, and we would love to present such solutions together with NGO Platform—could be an interesting option for this. Pooled funds are not only for humanitarian partners, and investment or private capital could be a partner to support this.
Mila Leonova: Yes, we work very close with our Government. Just this week, we will have our parliamentary hearing with civil society on board, where we will provide information for them. Together last year, for example, we created regulation for evacuation. Our civil society organisations were providers of necessary, important information from the field, but then Government approved this.
Also, for example, I have already mentioned this cross-sectoral concept, and we are working together with Ministries. What is important is that they really see us as partners. Just two months ago, a parliamentary Committee came to us with a draft law. This is very controversial, and we will support and provide our comments on it, and we need to improve it. But what is important is that they see in us a very important partner, because we continue and continue to support. We do not want to kick them out from the space. We understand the importance of Government. Something like evacuation, for example, is really something that we took, but we need to understand how, in the future, we can work together and create a system that will last for a long time, in a peaceful time, and how the Government should be a partner for this.
Chair: Thank you. Alex, any more?
Alex Sobel: I think that is fine for me.
Alina Belobra: Just to add to what Mila said about the co-operation with Government, we do see that the Government consistently see the value-add of NGOs and INGOs in their humanitarian work, not only on evacuation but also with IDP strategy development. In terms of IDP strategy development, the new strategy was recently developed and launched. On top of that, we are in conversation with the Government on how the byelaws are going to look, and how they describe the solutions for the IDPs to provide them with durable solutions in the longer term. I do believe that with this strategy, UK support for the Government and NGO support for the Government can create longer, more sustainable and more productive solutions for the livelihoods of the IDPs who are brought from the evacuation point and through the transit and collective sites.
Chair: Thank you. I am going to bring in another champion of Ukraine, David Taylor.
Mila Leonova: Maybe we will start with Illya, and then we will go.
Illya Kletskovskyy: First, I would like to thank the UK Government for supporting Ukraine and for having such a partnership, not only Government to Government, but also in terms of supporting civil society and business in Ukraine and the development of its communities, and responding to the dire humanitarian needs.
From the perspective of what can be done, and basically from talking with a lot of Ministries, it is about seeing if we can speed up the recovery aspects, seeing if we can look at the humanitarian and recovery needs jointly, and seeing how we can cover both and understand how people who are going through displacement and who have complex humanitarian needs can enter into the recovery. What kind of programmes or approaches do we need to introduce? What are the best practices? I very much think that it would be interesting and absolutely needed to bring these dimensions of humanitarian and recovery development together.
Also, of course, when you are looking at Ukraine right now, you will have a very different composition in communities now, with some communities on the frontline still struggling, and struggling economically, and you have the communities that are going through a different composition, where you have veterans and internally displaced populations. It is very important to have the correct strategy and a great partnership that can support Ukraine to develop the correct documents and correct approaches, and to look at where there are gaps and where we can speed up.
Of course, the No. 1 gap I see is the crossover between humanitarian and development aid.
Alina Belobra: I completely support those points. Maybe to reinforce them, we can say that we see that human resources capacity, as we heard in the previous session, but as we also know from our members at another level, at community level, is very strained. Salaries are also not very high.
So to complement the local authority and the Government capacity, some projects are developed jointly, as I am sure you know. What we see as essential is that social and public services continue to be supported, either through projects or through support for local authorities. Without them, it is going to be really hard for the NGOs to provide humanitarian assistance in a complementary way. Sometimes it is not going to be possible.
If we take the example of healthcare facilities and healthcare needs at the frontline right now, according to the data that we see from this year, a big proportion of the population at the frontline—almost half—is people aged 60-plus and pensioners. They are very vulnerable. Many of them are single women. That means they are exposed to protection risks. They are exposed to healthcare risks.
We were looking at the healthcare needs, and IMPACT Initiatives, the data and research think-tank, mentioned to us that almost half the healthcare needs in the frontline are for chronic diseases. We looked at why, and that is how we found this data.
Alina Belobra: There are several reasons. One is digital access, so having no access to certain types of information. There is also limited resources—limited income. Maybe there are other reasons that I am not accounting for, but these are very obvious ones.
Another thing is that, right now, according to IMPACT Initiatives, travel to healthcare facilities can take from 15 to 45 minutes, even if the healthcare facility is not located in your settlement, but in the neighbouring settlement. But we are approaching the winter, and fuel prices might ramp up, and the attacks—the security situation—might be exacerbated. Then, we are looking at places where there is no service provision in the community without the need to travel, and limited income does not allow you to travel too far. Then, we are potentially going to see pockets of healthcare needs. That is why I was talking about the need to support human capacities and human resources in service provision within the local or Government authorities.
Mila Leonova: To add to that, FCDO has such a rich and diverse portfolio, and it very important to introduce all the different bubbles to each other. Like I mentioned to Alex, the World Bank believe in their partners, and they work just in this framework. It is very important to facilitate and support these connections between different stakeholders.
Alliance was funded from the beginning by FCDO and that was very impactful. Ukrainian civil society is now a laboratory for solutions and for different products that we can provide, like the Minimum Duty of Care Package, for example. This is a great solution, not only for Ukraine.
It is important to drive this practical nexus—a magic word—and to work together with different departments. For example, social services and humanitarian aid should be together. I think it is very important that FCDO is now a great facilitator and trend provider for other donors. So please support us just with your presence, actually. You do already, but that is very important to continue.
Chair: It is really reassuring to hear that, and we hear what you are saying and we will relay that. David, you had a specific question?
Illya Kletskovskyy: In general, because of the attacks on the ports in Ukraine, you see a lot of those logistics and cargo movements outside of Ukraine and into Ukraine, rather than them using other means, such as sea ports, river ports or airports for cargo. So, in general, there is overstretched capacity at the border. Ukraine was trying to open new checkpoints and build new roads, and some checkpoints with Poland are under construction for that expansion.
Of course, it can fluctuate as well during the year, depending on how busy the cargo checkpoints or border controls and customs are into and outside Ukraine, especially into Ukraine. You will typically see huge lines from 1 km to 5 km standing at the border, and I would say that this is universal for all the borders, and maybe a bit more for the Polish border, because it remains the main transportation and logistics hub into Ukraine.
What is the solution for humanitarian aid here? Humanitarian or any other support coming into Ukraine for organisations like ours is all sustained there at the border. There are some regulatory simplifications for humanitarian aid, but the cargo must go through the same line as the rest—except for military aid, which I think is the only exemption. The rest goes through the same line, so of course delays are big. What we encourage is to procure as much as we can in Ukraine—whatever is available—rather than bring in humanitarian aid or cargo from outside. But, of course, this winter, when we are looking at boiler or generator solutions, procuring anything in Ukraine will take months—I would say three or four months—and we are already at the stage where we are relying on some of the movement of cargo from outside of Ukraine. It is a critical issue, but I am not aware of any possible solutions, because there are many different critical, even economic, supplies going into Ukraine.
It is also very important to mention, and you probably know, that for the past two months there has been an increase in attacks at the borders. Maybe it is a deliberate overfly zone for drones, but the borders need to close. Once again, it is a bit of economic pressure, with drones from the Russian Federation going very close to the European borders to inflict closure or a temporary wait on Ukraine until the air alerts go down. So that is an additional pressure to postpone delivery and create cargo lines.
Mila Leonova: I would love to support Illya with his idea to use Ukrainian farmers, for example, to provide support. We have a lot of projects like livelihood projects, and we have a great private sector now and solutions, so it is very important to use them. This is not only providing support, but pushing the economy. That is one question.
Another question is that we already have different state bodies, for example the Office of the President, driving that question with Ministries, and CSOs are taking this question onboard as well. So we try to solve these problems. But we need to use the Ukrainian market to provide support.
The follow-up question I had was regarding Nova Poshta, if I have pronounced that right. Apparently, they used to provide free delivery and no longer do. Some feel that that is hampering their efforts. Is it hampering yours? Do you have a view on that and whether Nova Poshta should go back to providing free help?
Illya Kletskovskyy: Can I ask you to clarify when you say it is free help? It is free delivery of what exactly?
Mila Leonova: Humanitarian aid, I think.
David Taylor: Yes. From what people have told me, they used to be able to use their services for free, to post certain items, not big bulk items, I am assuming, but certain items.
Illya Kletskovskyy: The Ukrainian Red Cross does have a partnership with Nova Poshta because it is the biggest logistics provider in Ukraine and they do support, pro bono, some humanitarian organisations. I think in the beginning, in 2022-23, it was in much larger capacities, just delivering. Right now, they do a lot for the Government as well in terms of the transportation, based on what I know, but they are quite open to partnerships and the discussions. Once again, I cannot comment on the value or volume, what has increased, what has not.
I will be open with you: we have a good partnership with Nova Poshta and they are providing us with free warehousing and logistics capacity. However, with the recent attacks, they have suffered quite a bit as well, so the Ukrainian Red Cross cannot use them right now. Although they are the biggest logistics provider, unfortunately they are being targeted at this particular moment.
Alina Belobra: This is a good question. Internally, we had quite an intensive conversation recently—with members of Alliance and members of NGO Platform—about the fact that Ukrainian society knows how to fundraise for military causes, but that the limited income of the population means they are facing the choice of whom to fund. It is no longer the choice of A and B; it becomes the choice of A or B. Then, it becomes increasingly hard to argue for humanitarian organisations.
NGO Platform has 140 members; half of them are international NGOs and their headquarters they do fundraising. Technically, there could be a learning-sharing experience and expertise found to be shared with Ukrainian organisations. What we hear from Ukrainian NGOs and CSOs is that they are questioning whether this will be fruitful, considering the limited income and the either/or choice. Maybe Mila can add to that.
Mila Leonova: We have only Ukrainian civil society on board. When the war started, and for now, we have plus 57% of charitable foundations. What does that mean? That means that people do not want to be volunteers; they would love to professionalise and institutionalise this support. We have a lot of different volunteer initiatives, and now they have a budget of dozens, millions, of euros. Why? These people came from the private sector, the medical sphere, from very different professional areas, and that means that they provide very technical and interesting solutions, very creative solutions. So now we have a new sector—really, responders. That is what we need to use in Ukraine. After the humanitarian crisis, these organisations can very easily “change their shoes” and will start to work with development, with recovery. They already work in this area.
That is why I maybe repeatedly and a bit annoyingly speak about introduction, because that is important: to introduce these organisations as very reliable partners to the private sector. They think that we are like beggars or maybe competitors to them because they would love to drive this—everyone would love to drive funding. But we survived in Ukraine because our horizontal connections supported us. Now we need to continue and we need to build this triangle in an equal manner, and we need to invest in this relationship.
For example, you have the investment agency. It will be very interesting when the agency can not only work for your members and invite not only the private sector to some meetings, but can also combine. I have a very specific example. I was invited to a security private sector meeting to speak about security, because they need to build their policies for EU integration. Our humanitarian organisation already passed this way, and can easily provide solutions. But who knows? That is why it is very important to have such mixed teams. What we represent now is very highly technical and very professional. We need to use this as a team and support.
Illya Kletskovskyy: Thank you so much for the question. Of course it is difficult and, at the same time, a bit of a privilege. When a country is at war, it is very divided in a sense because a lot of servicemen and other people go to fight for their country. Being a humanitarian worker or one of the volunteers gives you the privilege to support them, and you are in a very difficult situation, supporting the Government and humanitarian efforts. From one point of view, it is a very privileged position, but from another point of view, it is a very difficult position.
I do see a lot of our volunteers and staff, especially at the frontline already having trauma, psychological and healthcare issues that they need to deal with. Of course, almost five years of war has a big footprint on people’s lives and when you have responders, when you have volunteers that continue, I can see that it definitely influences their lives and their wellbeing.
In 2022, Ukrainian Red Cross increased. We started to increase numbers of volunteers and staff. Volunteers increased by 10 times because people were ready to go in and support their neighbours. We were just one of the organisations that provided the platform, although probably to do it a bit better and a bit more structured. However, I would say that society itself mobilised very quickly. Of course, being mobilised for years—for five years in a row—is very difficult. Some people can do it, and some people cannot do it. It depends as well on your economic status, on the possibilities.
Last winter, it was one thing to respond for one night and stand in a tent and provide some sort of heating or meal support to the population, but it is another thing when you stand 30 nights or 60 nights in a row. Of course, it is extremely difficult. I would say that it is very hard not to retain the volunteers but to engage them throughout. In 2022, volunteers were committed for a certain period of time. We need to manage this time because people have other life circumstances or commitments in their professional and personal life. Of course, it is difficult, but I very much hope that we have some sort of system already to manage the volunteers and engage with civil society.
I would also mention, to the previous question, that I think the civil society of Ukraine is still very much capable of responding. All are very fatigued, especially when we are talking about the winter and the blackouts, but I think the most crucial thing is civil society itself, when neighbours help their neighbours. This is the backbone of the humanitarian response.
Chair: Thank you. I am just endlessly impressed by the work of your volunteers and members, both at the Red Cross, but also in civil society and the NGOs that work in this field. I do not think any of us realised or could believe how long this has been going on for. The endurance that you have shown both as a nation and as individuals is truly remarkable and something to be honoured. Please express our gratitude to everybody who works alongside you.
Chair: At a practical level, what are you seeing NGOs doing in the humanitarian field?
Mila Leonova: They are like our first responders. When war started, who started this response? It was local actors. I already mentioned that we started with volunteers, but a lot of organisations became very strong and capable NGOs, and now they operate with dozens and dozens of millions.
Mila Leonova: Everything. All the clusters that we have—not only humanitarian aid, but development and recovery—do everything. It is very important that they do not want to duplicate. They try to fill the gaps.
For example, I already mentioned evacuation. This is a really big part of our work. This is a very dangerous area. Illya already mentioned the winter, but every day we have different messages from our members—evacuees are targeted every day. With the safaris, they target anything with a humanitarian emblem, and it is very important to provide support, because it is just a slogan now—humanitarians, we need to support them.
As well as local actors, we work around localisation. We have a localisation strategy in Ukraine, and we are working out how to improve the finance stream lines to share this access with local actors. For them, it is very hard to be part of the Ukrainian Humanitarian Fund, for example. That is why we are thinking about how to support them with strong representation of national actors and how we can have them on board. They are not only providers of needs and important information, but they can achieve things and act in very dangerous areas, at the frontlines. That is why it is super-important to support and to work together with national and local actors.
Alina Belobra: To build on what Mila just said, in terms of providing services, the services vary from going into communities and evacuating people, and providing them with information assistance and other types of assistance, including mental health support, to providing renovation, shelter and repairs in the collective sites and transit sites. People usually stay in transit sites for two to three days, and transit sites become the window for INGOs and NGOs to come and meet the population and to provide their assistance to the population.
That is with one caveat. There are self-evacuees; there are people who are evacuating by themselves using their own means, and they are falling through the cracks. We do not see them in the system. What we know about them is that they deplete their own resources, which means that they have more hardship adapting in those receiving communities in central and western Ukraine.
Alina Belobra: That is a good question. I think it is a combination of both, honestly. On one hand, it is a choice—again, this is according to our members and their data collection, and from conversation with the production cluster; I am referring too much to that today, I know, but it is more evidence that I can rely on. What we see is, first, personal reasons. Some people have their pets, but also some have hens, or whatever they want to have, and to evacuate with the animals they have requires more resources, so they either choose to stay and delay their evacuation to the last minute or they ask for information about living conditions with their animals. This is a limitation that was identified in the response in August this year.
There is also a second group, with a different reason for non-evacuation, which is people who evacuated, spent some time either abroad or in central and western Ukraine and then decided to return. Once they returned, they expressed less willingness and readiness to evacuate, up to the point when conditions become unbearable and then they need to evacuate. Then, their evacuation comes with more, I regret to say, additional risks for both the humanitarians who are doing the work, but also for the population, because when there were more opportunities, the decision was made to stay. But there is a variety of reasons, including the healthcare burden in families, when there is a family with a person with a disability or a family that has a person with limited mobility.
Mila Leonova: To add to that, they are citizens. That is why they do not want to leave. They would love to support and protect. I know people who did not evacuate during this wartime because they feel shame and ask, “How can I leave this space when my people need this support?” It is very important to support not only the beneficiaries, but humanitarians, these teams. That is why it is necessary to have flexible funding in budgets for such teams to even have retreats.
Chair: That makes a lot of sense. Thank you.
Chair: When it does end.
Alina Belobra: Honestly, it becomes harder to think of the scenarios, considering the timeline and considering the changed nature of warfare and its impact. In terms of what we see now, and what we try as NGO Platform to facilitate—I am not answering your question, but giving a different answer, which will maybe help or give you an idea of what people are thinking of now—there are basically two trains of thought. One is creating spaces, as Mila said earlier, for different stakeholders to meet. What we as a Platform do, what Alliance does and what we sometimes do jointly as well is we put hromadas and CSOs or NGOs together for them to identify the needs that exist in hromadas and the resources that the NGOs have to complement those needs. That is why, earlier, I was talking about those opportunities. If business is brought there, then we are talking about the nexus and development; if business is not there, we are talking—at least in my vision, and I might be wrong, so please correct me—about humanitarian assistance.
Another track—I am coming again to IDPs and their adaptations—is basically that the whole response right now is trying to look at the whole IDP journey. We understand the need to hyper-prioritise within the humanitarian plan because of limited resources and because of the need to select to whom to provide the assistance. We also know, as I mentioned earlier, that some people are going to fall through the cracks. So what we are trying to do jointly in the response is to identify the places where those people might fall through the cracks and to see who to bring into the conversation and how to build the dialogue around those issues so that we can see how to support that transition.
My one-sentence answer would be that all the same issues we see right now are going to exacerbate, because we will then have different directions of population movement—returns, people going abroad—and all sorts of different dynamics playing out. So I do believe that the thinnest places are going to be more tense and prone to breaking.
Chair: Thank you. I really appreciate all of you making the time to be with us today. It is an horrific situation that you find yourselves in, and not one of your own making. You have represented your organisations and members very well, and you have given us a very clear picture of the daily grind and horror that the people of Ukraine are enduring. Thank you for your work. Thank you for being with us today. And thank you for giving us an insight into what you are dealing with.